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A point prevalence study of hepatitis E virus (HEV) in Chinese blood donors was conducted, and the
prevalences of antibodies against HEV immunoglobulin G (IgG) and IgM among Chinese blood donors were
32.60% and 0.94%, respectively. HEV viremia was 0.07%.
Hepatitis E virus (HEV) can cause sporadic as well as
epidemic hepatitis. While HEV transmission usually occurs
by eating and drinking contaminated foods and water (4),
blood transfusion is another route of infection (1).
During HEV infection, the first antibody to appear is im-
munoglobulin M (IgM) at week 4, followed by IgG at week 5
(2). The usual length of IgM positivity is between 2 and 3
months. Viremia appears during acute HEV infection at week
2 and normally lasts for 2 to 3 weeks but can last for up to 112
days (1).
In China, HEV seroprevalence of the general population
is about 40% and increases with age at a rate of about 1%
per year (3). Acute infection, as estimated by the prevalence
of IgM anti-HEV and the spontaneous rise of IgG anti-HEV
levels, occurs at about 4% per year. Asymptomatic viremia
has been estimated to be approximately 0.3% (5). With such
figures, an appreciation of the prevalence of HEV in Chi-
nese blood donors seems prudent from a public health per-
spective.
Eligible plasma samples (n  44,816) were collected from
6 urban blood centers in China during the past 7 years (from
approximately December 2002 to October 2008). Demo-
graphic details of the sex and age of the subjects are pro-
vided in Table 1. All donors tested negative for syphilis,
hepatitis B and C, HIV type 1, and HIV type 2, had normal
alanine aminotransferase (ALT) levels, and had no signs of
acute virus hepatitis at the time of donation.
Antibodies against HEV IgG and IgM were tested by
commercial enzyme-linked immunosorbent assay (ELISA)
kits (Wan Tai, Beijing, China), according to manufacturer’s
instructions. Table 2 shows that the HEV seroprevalences of
blood donors ranged from 29.9% to 41.7%. As estimated by
use of IgM anti-HEV, the rates of acute HEV infection
ranged from 0.43% to 1.51%. All anti-HEV IgM-reactive
samples were also anti-HEV IgG positive.
A random selection of 420 anti-HEV IgM-reactive sam-
ples and more than 100 negative (including IgG-positive and
-negative) samples were tested for HEV RNA using an
in-house PCR system. RNA was extracted from 250 l of the
specimen with Trizol (Invitrogen). Reverse transcription-
PCR (RT-PCR) was then performed (3, 5), with a 150-bp
fragment of the viral genome carried by ORF2 being am-
plified and sequenced. The nucleotide sequences of the am-
plified products were aligned by using Jotun-Hein methods
in the software program MegAlign (DNAStar package ver-
sion 7.1.0, Lasergene; DNAStar, Inc., Madison, WI). The
rates of viremia among the donors in 6 different regions of
China ranged from 0.02% (Xiamen) to 0.14% (Huzhou)
(P  0.01). These results also showed a high prevalence of
viremia among anti-HEV IgM-positive samples. A total of
7.14% (30/420) of anti-HEV IgM-positive samples were
RNA positive, but none of the IgM-negative samples were
HEV RNA positive. Phylogenetic analysis shows that 17 of
30 isolates belonged to genotype 1, and the remaining 13
belonged to genotype 4 (GenBank accession no. FJ606805
and FJ972142 to FJ972170).
In conclusion, HEV presents a risk of infection through blood
transfusion in China, with a high prevalence of viremia among
anti-HEV IgM-positive samples. Preventive strategies such as se-
rological screening of anti-HEV IgM of donors should be intro-
duced to reduce transfusion-transmitted risk for HEV infections.
This may be of especial importance to individuals who are immu-
nocompromised or who are unable to achieve viral clearance and
thus may suffer from other clinical consequences.
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TABLE 1. Age-related prevalences of HEV RNA in male and
female blood donors
Age group
(yr)
% of samples positive for HEV RNA (no. of samples positive/
total no. of samples)
Male Female Total
20 0.08 (3/3,941) 0.06 (3/5,078) 0.07 (6/9,019)
21–40 0.07 (14/19,359) 0.07 (9/12,710) 0.07 (23/32,069)
41 0.04 (1/2,299) 0 (0/1,429) 0.03 (1/3,728)
Total 0.07 (18/25,599) 0.06 (12/19,217) 0.07 (30/44,816)
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Nucleotide sequence accession numbers. The sequences
newly determined in this work are available in GenBank under
accession no. FJ972142 to FJ972170.
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TABLE 2. Prevalences of anti-HEV IgG, anti-HEV IgM, and HEV RNA in blood donors
Areaa Time collected(mo/yr)
No. of donors (% positive)
Total IgG anti-HEV IgM anti-HEV HEV RNA
HZ 12/2002–4/2003 3,047 1,271 (41.71) 46 (1.51) 6 (0.20)b
WH 2/2005–4/2005 10,136 3,175 (31.32) 92 (0.91) 10 (0.10)
XM 3/2005–4/2007 20,389 6,215 (30.48) 186 (0.91) 4 (0.02)b
SX 6/2005–5/2006 3,701 1,107 (29.91) 50 (1.35) 5 (0.14)
QZ 4/2006–4/2007 4,860 1,974 (40.62) 21 (0.43) 2 (0.04)
WZ 2/2008–10/2008 2,683 866 (32.28) 25 (0.93) 3 (0.11)
Total 12/2002–10/2008 44,816 14,608 (32.60) 420 (0.94) 30 (0.07)
a Abbreviations: HZ, Huzhou; WH, Wuhan; XM, Xiamen; SX, Shaoxing; QZ, Quzhou; WZ, Wenzhou.
b The differences between Huzhou and Xiamen were statistically significant (P  0.01).
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